How long does gabapentin stay in urine

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Gabapentin Detection in Urine: Duration and Pharmacokinetics

Pharmacokinetics of Gabapentin

Gabapentin is a water-soluble antiepileptic drug that is rapidly absorbed and exhibits dose-dependent bioavailability due to a saturable transport mechanism . It is not protein-bound and has a high volume of distribution, indicating a greater concentration in tissue than in plasma . Importantly, gabapentin is not metabolized and is excreted unchanged in the urine . This characteristic simplifies its pharmacokinetic profile, as metabolism-related factors do not necessitate dosage alterations after prolonged therapy .

Elimination Half-Life and Urinary Excretion

The elimination half-life of gabapentin is approximately 5 to 9 hours, which necessitates three divided doses per day to maintain steady-state plasma concentrations . The drug's plasma clearance is linearly related to creatinine clearance, making it essential to adjust dosages based on renal function .

Impact of Renal Function on Gabapentin Clearance

Renal function significantly impacts the pharmacokinetics of gabapentin. In subjects with impaired renal function, the apparent oral plasma clearance (CL/F) and renal clearance (CLR) of gabapentin decrease, leading to higher plasma concentrations and longer elimination half-lives . Despite these changes, the total urinary recovery of unchanged gabapentin remains comparable across individuals with varying degrees of renal function, indicating that the extent of drug absorption is unaffected by renal impairment .

Duration of Gabapentin in Urine

Gabapentin can be detected in urine for an extended period, especially in individuals with reduced renal function. In a study involving subjects with various degrees of renal function, urine samples were collected for up to 264 hours (11 days) after dosing to determine gabapentin concentrations . This extended detection window highlights the importance of considering renal function when interpreting urine drug tests for gabapentin.

Conclusion

Gabapentin is excreted unchanged in the urine, and its detection in urine can last up to 11 days, particularly in individuals with impaired renal function. The drug's pharmacokinetics, including its elimination half-life and clearance, are significantly influenced by renal function, necessitating dosage adjustments based on creatinine clearance. Understanding these factors is crucial for accurate interpretation of urine drug tests and effective management of gabapentin therapy.

Sources and full results

Most relevant research papers on this topic

Pharmacokinetics of gabapentin in subjects with various degrees of renal function

Impaired renal function leads to higher plasma gabapentin concentrations, longer elimination half-lives, and reduced creatinine clearance, suggesting that dosing regimens can be adjusted based on creatinine clearance.

Observational StudyHighly Cited

1994·

143citations

·R. Blumet al.

Clinical Pharmacology & Therapeutics

Clinical pharmacokinetics of gabapentin

Gabapentin is a rapidly absorbed, dose-dependent antiepileptic drug with unique pharmacokinetic properties, making it a promising alternative to standard antiepileptic drugs and oral contraceptives.

Highly Cited

1994·

176citations

·M. McLean

Neurology

Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients.

Tiagabine significantly reduced cocaine taking behavior compared to placebo or gabapentin in methadone-stabilized cocaine abusers.

RCTHighly Cited

2007·

82citations

·Gerardo Gonzálezet al.

Drug and alcohol dependence

Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.

Gabapentin reduces opioid use during a 10-day buprenorphine detoxification procedure, potentially improving outcomes for opioid-dependent individuals.

RCT

2013·

34citations

·Nichole Sanderset al.

Experimental and clinical psychopharmacology

Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability

Gabapentin absorption has a wide range between subjects, but a much smaller variability within a subject, making plasma drug monitoring useful for assessing dose individualization.

RCTHighly Cited

2000·

142citations

·B. Gidalet al.

Epilepsy Research

A randomized placebo-controlled trial of gabapentin for cocaine dependence.

Gabapentin 1600 mg bid combined with relapse-prevention therapy was no more effective than placebo in treating cocaine dependence.

RCTHighly Cited

2006·

80citations

·A. Bisagaet al.

Drug and alcohol dependence

Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.

Gabapentin, an antiepileptic drug, exhibits desirable pharmacokinetic properties, with linear elimination kinetics, minimal binding to plasma proteins, minimal metabolization, and no hepatic cytochrome P450 inducer.

Non-RCTAnimal StudyHighly Cited

1995·

140citations

·L. Radulovicet al.

Drug metabolism and disposition: the biological fate of chemicals

Daily gabapentin improved behavior modification progress and decreased stress in shelter cats from hoarding environments in a double-blind randomized placebo-controlled clinical trial.

Daily gabapentin improves behavior modification progress and reduces stress in fearful shelter cats from hoarding environments.

RCTAnimal Study

2023·

3citations

·B. Eaganet al.

Journal of the American Veterinary Medical Association

A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.

Gabapentin may prevent relapse to heavy drinking in alcohol-dependent patients by a physiological mechanism not measured in this study.

RCTHighly Cited

2008·

171citations

·K. Broweret al.

Alcoholism, clinical and experimental research

Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance.

Continuous peritoneal dialysis effectively treats gabapentin toxicity, providing clearance similar to urea clearance and providing a slow but effective treatment for overdose and toxicity.

Case Report

2017·

7citations

·H. Ibrahimet al.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Try another search

space view of earth

space shuttle takeoff

space station altitude

what's the big bang theory

astronomy science

climate change the facts